[NH2:1][C:2]1[C:9]([NH2:10])=[CH:8][CH:7]=[C:6]([N:11]2[CH2:16][CH2:15][CH2:14][CH:13]([C:17]([F:20])([F:19])[F:18])[CH2:12]2)[C:3]=1[C:4]#[N:5].[Cl:21][C:22]1[CH:38]=[CH:37][C:25]([CH2:26][NH:27][C:28]([C:30]2([C:33]([F:36])([F:35])[F:34])[CH2:32][CH2:31]2)=[O:29])=[CH:24][C:23]=1[N:39]=[C:40]=S.C(Cl)CCl>CN(C=O)C>[Cl:21][C:22]1[CH:38]=[CH:37][C:25]([CH2:26][NH:27][C:28]([C:30]2([C:33]([F:36])([F:35])[F:34])[CH2:31][CH2:32]2)=[O:29])=[CH:24][C:23]=1[NH:39][C:40]1[NH:10][C:9]2[CH:8]=[CH:7][C:6]([N:11]3[CH2:16][CH2:15][CH2:14][CH:13]([C:17]([F:20])([F:18])[F:19])[CH2:12]3)=[C:3]([C:4]#[N:5])[C:2]=2[N:1]=1The title compound was prepared in analogy to Example 71 using 2,3-diamino-6-(3-trifluoromethyl-piperidin-1-yl)benzonitrile (115 mg, 0.40 mmol), N-(4-chloro-3-isothiocyanatobenzyl)-1-(trifluoromethyl)cyclopropane carboxamide (135 mg; 0.40 mmol), EDC (77 mg, 0.40 mmol) and DMF (3 mL).